Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

Kidney International

Volumn 56, Issue 3, 1999, Pages 1037-1048

  Kato, Shinichiro ^a   Luyckx, Valerie A ^a   Ots, Mai ^a   Lee, Kang Wook ^a   Ziai, Farzad ^a   Troy, Julia L ^a   Brenner, Barry M ^a   Mackenzie, Harald S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Candesartan; Diabetic nephropathy; Enalapril; Glomerular injury; Macrophage recruitment; Monocyte transmigration; Proteinuria

Indexed keywords

CANDESARTAN; ENALAPRIL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; IMMUNOHISTOLOGY; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032825219     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00643.x     Document Type: Article

References (59)

1. 1. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 28:91-100, 1971
2. 2. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving H-H: Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21:683-688, 1982
3. 3. Nelson RG, Bennett PH, Beck GJ, Tang M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335:1636-1642, 1996
4. 4. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
5. 5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986:1925-1930, 1986
6. 6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
7. 7. Schreiner GF, Cotran RS, Unanue ER: Macrophages and cellular immunity in experimental glomerulonephritis. Springer Semin Immunopathol 5:251-267, 1982
8. 8. Bolton WK, Innes DJ, Sturgill BC, Kaiser DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathological correlations. Kidney Int 32:869-876, 1987
9. 9. Eddy AA, McCulloch L, Liu E, Adams J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 138:1111-1123, 1991
10. 10. Klahr S, Ishidoya S, Morrissey J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146, 1995
11. 11. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
12. 12. Furuta T, Satto T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21:480-485, 1993
13. 13. Yoshimura T, Robinson EA, Tanaka S, Appela E, Leonard EJ: Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear cells. J Immunol 142:1956-1962, 1989
14. 14. Capers Q IV, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR: Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30:1397-1402, 1997
15. 15. Siivy Y-J, Hsieh H-J, Usami S, Chien S: Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA 91:4678-4682, 1994
16. 16. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82:5963-5967, 1985
17. 17. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CO, Matsushima K: Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 144:3034-3041, 1990
18. 18. Rovin BH, Yoshimura T, Tan L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153, 1992
19. 19. Ketteler M, Noble NA, Border WA: Transforming growth factor-beta and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis. Annu Rev Physiol 57:279-295, 1995
20. 20. Yokoyama H, Deckert T: Central role of TGF-β in the pathogenesis of diabetic nephropathy and macromolecular complications: A hypothesis. Diabet Med 13:313-320, 1996
21. 21. Bertoluci MC, Schmid H, Lachat J-J, Coimbra TM: Transforming growth factor-beta in the development of rat diabetic nephropathy. Nephron 74:189-196, 1996
22. 22. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis in the rat induced by anti-mesangial cell antibodies. Am J Pathol 136:369-374, 1990
23. 23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
24. 24. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 92:8729-8733, 1995
25. 25. Yoshimura T, Takeya M, Takahashi K: Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 174:504-509, 1991
26. 26. Kita Y, Takashi T, Iigo Y, Tamatani T, Miyasaka M, Horiuchi T: Sequence and expression of rat ICAM-1. Biochim Biophys Acta 1131:108-110, 1992
27. 27. Williams AJ, Atkins RC, Fries JWU, Gimbrone MA Jr, Cybulsky MI, Collins T: Nucleotide sequence of rat vascular cell adhesion molecule-1 cDNA. Biochim Biophys Acta 1131:214-216, 1992
28. 28. Scotte M, Hiron M, Masson S, Lyoumi S, Banine F, Teniere P, Lebreton JP, Daveau M: Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxin-or turpentine-induced inflammation in rat. Cytokine 7:115-120, 1996
29. 29. Borycki A-G, Lenormand J-L, Guillier M, Leibovitch SA: Isolation and characterization of a cDNA clone encoding for rat CSF-1 gene: Post-transcriptional repression occurs in myogenic differentiation. Biochim Biophys Acta 1174:143-152, 1993
30. 30. Chehadeh HE, Zerlauth G, Mannhalter JW: Video image analysis of quantitative competitive PCR products: Comparison of different evaluation methods. Biotechniques 18:27-28, 1995
31. 31. Hancock WW, Becker GJ, Atkins RC: A comparison of fixatives and immunohistochemical techniques for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol 78:825-830, 1982
32. 32. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
33. 33. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short-and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
34. 34. US Renal Data System: USRDS 1997 Annual Data Report. Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997
35. 35. Sayer-Hansen K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23:643-646, 1983
36. 36. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
37. 37. Yamamoto T, Nakamura N, Noble NA, Ruoslahti E, Border W: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
38. 38. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
39. 39. Stahl RAK, Thaiss F, Disser M, Helmch U, Hora K, Schlondorff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody induced glomerulonephritis. Kidney Int 44:1036-1047, 1993
40. 40. Rovin BH, Rumancik M, Tan L, Dickerson J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71:536-542, 1994
41. 41. Tabbara IA, Robinson BE: Hematopoietic growth factors. Anti-cancer Res 11:81-90, 1991
42. 42. Border WA, Noble NA, Ketteler M: TGF-beta: A cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int 49(Suppl):S59-S61, 1995
43. 43. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
44. 44. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetic mellitus. Kidney Int 49:1120-1126, 1996
45. 45. Park IS, Kiyomoto H, Abboud SL, Abboud HE: Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
46. 46. Lee LK, Meyer TW, Pollock AS, Lovett DM: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964, 1995
47. 47. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 51:1553-1567, 1997
48. 48. Tamaki K, Okuda S, Nakayama M, Yanagida T, Fujishima T: Transforming growth factor-β1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol 7:2578-2589, 1996
49. 49. Noble NA, Border WA: Angiotensin II in renal fibrosis: Should TGF-β rather than blood pressure be the therapeutic target? Semin Nephrol 17:455-466, 1997
50. 50. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 90:456-461, 1992
51. 51. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
52. 52. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity on proximal tubule. Kidney Int 41:107-114, 1992
53. 53. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
54. 54. Yang C-W, Vlassara H, Peten EP, He C-J, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
55. 55. Cohen M, Sharma K, Jin Y, Hud E, Wu V-Y, Tomaszewski J, Ziyadeh FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. J Clin Invest 95:2338-2345, 1995
56. 56. Ziyadeh FN, Sharma K: Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int 48(Suppl 51):S34-S36, 1995
57. 57. Klein RM, MacGillivray BK, McKenzie JC: Markers of cardiac hypertrophy. Ann NY Acad Sci 752:210-217, 1995
58. 58. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL: Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 63:519-528, 1997
59. 59. Schiller B, Moran J: Focal glomerulosclerosis in the remnant kidney model: An inflammatory disease mediated by cytokines. Nephrol Dial Transplant 12:430-437, 1997